PMC:7228307 / 2656-2982 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"35","span":{"begin":140,"end":161},"obj":"Disease"},{"id":"36","span":{"begin":174,"end":181},"obj":"Disease"},{"id":"37","span":{"begin":212,"end":224},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D007249"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:D009369"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"the most clinically successful therapeutic modalities across a diverse array of diseases. They have revolutionized the treatment of chronic inflammatory diseases and of some cancers including otherwise incurable malignancies.1 They are commercially important and in 2017, five mAbs collectively grossed $45.6 billion in sales,"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":140,"end":161},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"the most clinically successful therapeutic modalities across a diverse array of diseases. They have revolutionized the treatment of chronic inflammatory diseases and of some cancers including otherwise incurable malignancies.1 They are commercially important and in 2017, five mAbs collectively grossed $45.6 billion in sales,"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T31","span":{"begin":61,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"the most clinically successful therapeutic modalities across a diverse array of diseases. They have revolutionized the treatment of chronic inflammatory diseases and of some cancers including otherwise incurable malignancies.1 They are commercially important and in 2017, five mAbs collectively grossed $45.6 billion in sales,"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":320,"end":325},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_24866"}],"text":"the most clinically successful therapeutic modalities across a diverse array of diseases. They have revolutionized the treatment of chronic inflammatory diseases and of some cancers including otherwise incurable malignancies.1 They are commercially important and in 2017, five mAbs collectively grossed $45.6 billion in sales,"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T13","span":{"begin":80,"end":88},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T14","span":{"begin":153,"end":161},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"the most clinically successful therapeutic modalities across a diverse array of diseases. They have revolutionized the treatment of chronic inflammatory diseases and of some cancers including otherwise incurable malignancies.1 They are commercially important and in 2017, five mAbs collectively grossed $45.6 billion in sales,"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"35","span":{"begin":140,"end":161},"obj":"Disease"},{"id":"36","span":{"begin":174,"end":181},"obj":"Disease"},{"id":"37","span":{"begin":212,"end":224},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"pubann:denotes","subj":"35","obj":"MESH:D007249"},{"id":"A36","pred":"pubann:denotes","subj":"36","obj":"MESH:D009369"},{"id":"A37","pred":"pubann:denotes","subj":"37","obj":"MESH:D009369"}],"text":"the most clinically successful therapeutic modalities across a diverse array of diseases. They have revolutionized the treatment of chronic inflammatory diseases and of some cancers including otherwise incurable malignancies.1 They are commercially important and in 2017, five mAbs collectively grossed $45.6 billion in sales,"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T6","span":{"begin":140,"end":161},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"the most clinically successful therapeutic modalities across a diverse array of diseases. They have revolutionized the treatment of chronic inflammatory diseases and of some cancers including otherwise incurable malignancies.1 They are commercially important and in 2017, five mAbs collectively grossed $45.6 billion in sales,"}